Pharmaterials Ltd The Queen's Awards for Enterprise 2008
Home
Company Locations
Careers
Initiate a Project
Contact Us
Request A Brochure
Search Our Site
Home | COMPANY    |     SCREENING & PHYSICAL PROPS.    |     FORMULATION DEVELOPMENT    |     CONSULTANCY / COURSES    |     GMP PRODUCTION    |     NEWS    |    
Formulation Development
API Solubility Enhancement Preclinical Formulation Clinical Formulation Solid Oral Dosage IntraSOLV Solid Dispersions MacroSOLV Formulation Screen Inhaled Drug Delivery

Inhaled Drug Delivery - Formulation Development

Pharmaterials provides a contract, fee for service, offering for the formulation of dry powder inhalers (DPIs) and pressurized metered dose inhalers (pMDIs). Our specialization covers both small molecules (such as inhaled corticosteroids, beta agonists etc) and macromolecules (such as antibodies, vaccines etc). Our business also expands to the formulation of intranasal products

Whatever your respiratory drug delivery needs we are happy to provide:

  • early stage pre-formulation support
  • candidate drug selection support
  • design and engineering of particles suitable for inhalation
  • material characterization and sourcing
  • drug-excipient compatibility testing
  • formulation development of inhalation and intranasal drug products
  • development and optimization of manufacturing processes e.g. particle size reduction process
  • selection of an inhaler device.
  • in vitro testing of prototype formulations
  • stability testing of drug and formulations
  • development of cleaning verification processes

We can offer both conventional and bespoke technologies such as:

  • Air-jet milling (micronisation)
  • Spray drying
  • Freeze drying
  • Controlled crystallization
  • Inhalation powder blending
  • Microfluidisation
  • Pressure and cold propellant filling technology
  • Vibratory sieving of carrier particles 
  • Geometric particle size distribution
  • Aerodynamic particle size distribution
  • Impurities testing
  • Emitted dose testing
  • Surface morphology determination
  • Powder blend homogeneity
  • Solubility of drug in the propellant such as HFA 134a and 227ea
  • Solid state form changes induced by drug exposure to propellant
  • Primary, secondary and tertiary structures of macromolecules
  • Stability testing

Equipment

  • Sturtevant Qualification Micronizer
  • Lab Plant spray-drying equipment
  • Freeze-drying equipment
  • TurbulaŽ mixer
  • Vibratory sieves
  • Pamasol lab plant propellant filling and crimping equipment
  • Microfluidiser
  • NGI
  • DPI and pMDI total trap sampling apparatus
  • TSI Aerodynamic particle sizer
  • Malvern mastersizer
  • Thermal analysis equipment (DSC MC-DSC, ITC, TGA, DVS)
  • X-Ray powder diffraction
  • SEM and TEM
  • Specific surface area analyser (B.E.T)
  • Surface energy analysis (IGC)
  • Spectroscopy (i.e. IR, Raman, UV/VIS, FLD, CD)
  • Chromatography (HPLC-UV/FLD, SEC-UV/FLD)

Please contact us for full details of this service at enquiries@pharmaterials.co.uk

 

  Home  |  Company  |  Screening & Physical Props.  |  Formulation Development  |  Consultancy / Courses  |  GMP production  |  News  |  Site Map
© 2008 Pharmaterials Ltd, All rights reserved.       Site by : UKWebCo.com